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Abstract
Background: Slow decline in the incidence of tuberculosis (TB) has been observed in most high TB burden
countries. Knowledge of the prevalence of different TB risk factors can help expand TB control strategies. However
with the exception of Human Immunodeficiency Virus (HIV) the prevalence of the other TB risk factors are poorly
studied in Uganda. We aimed to determine the prevalence of different TB risk factors and TB disease presentation
among TB patients in Kampala Uganda.
Methods: We assessed 365 adult TB patients and used descriptive statistics to summarize their socio-demographic,
clinical, radiological, sputum mycobacteriology and TB risk factors (HIV, diabetes, TB contact, alcohol use, tobacco
smoking, poverty and overcrowding) data.
Results: A total of 158 (43.3%) patients were male and the median age was 29 (IQR 28–30). Majority of the patients
(89.2%) had pulmonary TB, 86.9% were new and 13.2% were retreatment. Wasting (i.e. body mass index of <18.5 kg/m2)
was found in 38.5% of the patients and 63% presented with cough. Constitutional symptoms (fever, anorexia, night
sweats and weight loss) were reported by 32.1%. Most patients (78.6%) presented with non-cavity lung parenchyma
disease (infiltrates, nodules, masses) but 35.2% had cavity disease. Pleural disease was detected in 19.3% of patients.
Positive smear microscopy and culture (irrespective of month of treatment) was found in 52.7% and 36.5% of patients
respectively. Any drug resistance was detected in 21.1% of patients while multidrug resistance (MDR) TB defined as
resistance to rifampicin and isoniazid was detected in 6.3% of patients. All MDR patients were new patients.
The prevalence of TB risk factors were as follows: HIV 41.4%, diabetes 5.4%, close contact 11.5%, family history 17.5%,
smoking 26.37%, poverty 39.5%, overcrowding 57.3% and alcohol use 50.7%. Overcrowding increased smear positive rate,
prevalence ratio 1.22, p = 0.09 but all the other studied risk factors did not affect clinical, radiological and
mycobacteriological study patient characteristics.
Conclusions: Among TB patients in Kampala, Uganda, there is high prevalence of the known TB risk factors. Targeting
reducing their prevalence may lead to better TB control in the country. Tuberculosis, risk factors, Uganda.
Background
Uganda is one of the 22 high tuberculosis (TB) bur-
den countries (HBC) in the world [1]. From an esti-
mated population of 35 million people with national
HIV prevalence of 7.3%, 45,546 TB patients were di-
agnosed in the in the year 2010 of which 54% were
HIV-infected [1-4]. Of these 56% were smear positive,
28% were smear negative and 11% had extra pulmon-
ary TB [1].
Despite implementation of the WHO recommended
directly observed therapy short course(DOTS)TB con-
trol strategy, the reductions in the incidence of TB have
been minimal in HBC [5]. Because of this slow decline
of TB incidence there is currently renewed interest in
finding new TB control strategies. Focus has been on
such strategies as adding to the current arsenal of TB
drugs, finding a TB vaccine and designing shorter TB
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regimens. However, knowledge of what makes some per-
sons develop TB and others not (risk factors) has poten-
tial of helping further to refocus the search for novel
public health TB control strategies. Reported TB risk
factors include HIV infection, male sex, co-morbidities
such as diabetes, and family history of TB, absence of a
Bacillus Calmette–Guérin (BCG) scar, smoking, alcohol
use, single marital status, overcrowding, and poor socio-
economic status [6-9].
Infection with HIV has been the mostly associated risk
factor for TB diseases in most HBC. [1] However, epide-
miologic studies have found that not all TB cases can be
attributed to HIV [10-13]. For example in Tanzania the
population attributable fraction of TB due to HIV was
29% while in Nigeria it was reported as 40% [11,12].
These findings highlight the importance of other TB risk
factors in perpetuating TB epidemics. Two of the risk
factors that are increasingly being recognized as major
drivers of the TB epidemic are tobacco smoking and dia-
betes [14-16]. Basu et al. through a mathematical model
have shown that if current smoking trends continue, to-
bacco smoking will be responsible for 18 million TB
cases and 40 million deaths in the next 40 years [17]. A
recent meta-analysis has found a strong association
(relative risk of 3.1) between TB and diabetes [18]. The
association between TB, tobacco smoking and diabetes
highlight the likely convergence of the emerging non
communicable diseases (NCD) epidemic in developing
countries and communicable diseases such as tubercu-
losis [19].
We conducted this study to determine the prevalence
of known TB risk factors among TB patients diagnosed
in Kampala district in Uganda and explore their effect
on clinical, radiological and mycobacteriological TB dis-
ease presentation.
Methods
Design and setting
This was across sectional study of patients from selected
government TB diagnostic and treatment units (DTUs)
in Kampala district. Participating DTUs were: Kisenyi
Health Center, Kiruddu Health Center, Kawaala Health
Center, Kitebi Health Center, Kawempe Health Center,
Kiswa Health Center and Mulago hospital. Kampala
district was chosen because of its accessibility and large
number of TB patients from all over the country (25%
of total national TB notifications are from Kampala
district) [20].
Study participants
Participants were adult TB patients aged 18 years and
above consecutively enrolled from participating DTUs
during the period September 2012 through February
2013.
Sample size calculation
Because the prevalence of most of the studied risk fac-
tors was not known we assumed a 50% prevalence rate.
Targeting a precision of 0.05 and standard normal devi-
ation at 95% confidence of 1.96 and allowing 10% non-
response rate we estimated that 423 patients would be
required to obtain precise estimates of the prevalence of
the studied risk factors. This was not attained due to
slow enrolment and an unexpected TB drugs stock out
during the study period that affected enrolment of pa-
tients who were on continuation phase of TB treatment.
Study procedures
Patients were interviewed using a structured question-
naire to collect demographic, socioeconomic and TB
symptom data. All patients provided one sputum sample
for mycobacteriological tests. At the study laboratory,
smear microscopy was done by concentrated fluorescent
microscopy method, after culture inoculation [21]. All
samples were decontaminated for culture using standard
operating procedures and all cultures were incubated for
up to 8 weeks on two Lowenstein Jensen (LJ) media
[22]. Culture results were communicated to the health
facilities for patient management. A patient’s culture re-
sult was considered contaminated only if all LJ slants
had non-mycobacterial growth, otherwise, positive result
was taken as a single colony on solid media and AFB on
Ziehl-Neelsen microscopy and/or capilia TB Neo™ posi-
tive, if doubtful colonies were observed. The absence of
colonies on LJ medium after 8 weeks was reported as
a negative result. Positive cultures underwent Drug
Susceptibility Testing (DST) testing to determine if
drug resistance was present. DST was performed by
Automated Mycobacterial Growth Indicator tube method
(MGIT960) as previously described [22].
Only patients at TB treatment initiation (month 0)
underwent chest X-ray (CXR) examination and fasting
blood sugar testing. Blood sugar was measured by Cobas
intergra 400 version 3.4.4.0809 machine. All patients
were HIV tested according to the ministry of health
rapid HIV testing algorithm [23].
Definition of variables
Tobacco smoking was defined as current or former use
of at least 100 cigarettes in a life time [24]. Alcohol use
was defined as history of drinking alcohol at least three
times a week as previously used in other alcohol use
studies in Uganda [24]. We defined poverty as a daily in-
come of less than 1.25 USD/day [25] while overcrowding
was defined as two or more adult persons who are not
of opposite sex sharing a room [26].
Diagnosis of diabetes was made according to American
Diabetes Association cut off ranges (<99 mg/dL, normal,
100-125 mg/dL, pre diabetes and ≥126 mg/dL, diabetes)
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[27]. We did not consider symptoms to make a diagnosis
of diabetes. Abnormal CXR was defined as any abnor-
mality on the CXR. Chronic cough was defined as cough
lasting two or more weeks.
Data analysis
Data were entered into an access database, cleaned and
analyzed using epi-info software version 3.54. Descriptive
statistics was used to summarize patients’ socio-
demographic, clinical, radiological and mycobacteriologi-
cal characteristics. Prevalence of different risk factors was
calculated as a proportion of those with the risk factor
divided by the total number of patients who had data for
that risk factor. Proportions of key clinical (chronic
cough), mycobacteriology (smear positivity) and radio-
logical (abnormal CXR) were calculated and compared
between the different risk factors studied using a t-test. A
p value of <0.05 was considered to represent significant
difference.
Ethics consideration
All patients provided written informed consent. Ethical
approval was obtained from the Makerere University
School of Biomedical Science Research and Ethics com-
mittee and from the Uganda National Council of Science
and Technology. Each patient was assigned a unique
study number for identification. Patient’s names were
not used on any study related documents. Study docu-
ments were kept under lock and key.
Results
Socio-demographic characteristics
A total of 365 TB patients were recruited during the
study period. One hundred and forty one (38.6%) were
at month zero, 84 (23.0%) were at month two, 64
(17.5%) were at month 5, 33 (9.0%) were at month six
and 43 (11.8%) were at month eight of TB treatment.
Study patients characteristics are shown in Table 1.
Male patients were 158 (43.3%), median age was 29
(IQR 28–30) and 296 (81.1%) were under the age
40 years.
Majority of the patients (89.2%) had pulmonary TB,
86.9% were new and 13.2% were retreatment. 38.5%
were wasted (i.e. body mass index of <18.5 kg/m2) and
63% presented with cough. Constitutional symptoms
(fever, anorexia, night sweats and weight loss) were
reported by 32.1%.
Most (78.6%) presented with either infiltrates, nodules
or masses, 35.2% cavities and 19.3% of the patients had
TB disease presenting with pleural effusion and/or
thickening.
Positive smear microscopy and culture (irrespective
of month of treatment) was found in 52.7% and 36.5%
of patients respectively. Of the 95 patients with 95
isolates any drug resistance was detected in 21.1% of
patients while multidrug resistance (MDR) TB defined
as resistance to rifampicin and isoniazid was detected
in 6.3% of patients. All MDR patients were new.
TB risk factors
The prevalence of each of the investigated TB risk fac-
tors is shown in Table 2. The prevalence of HIV infec-
tion was 41.4% (151 of 365) while that of diabetes was
Table 1 Study patients’ characteristics
Characteristic Level No (%)
Demographic characteristics
Age <40 296 (81.1%)
41-65 68 (18.6%)
>65 1 (0.3%)
Gender Male 158 (43.3)
Female 207 (56.7)
Occupation Un/ self-employed 110 (64.0%)
Employed 62 (36.0%)
Education None 19 (5.2)
Primary 110 (30.1)
Secondary 39 (10.7)
Tertiary 108 (29.6)
Clinical characteristics
Site of TB (260) Pulmonary 232 (89.2)
Extrapulmonary 28 (10.8)
Treatment category New 317(86.9)
Retreatment 48(13.2)
BMI < 18.5 kg/m2
(n = 234)
<18.5 90 (38.5)
TB symptoms (n = 365) Cough 230 (63.0)
Constitutional symptoms 117 (32.1)
HIV infection (n = 365) HIV infected 153(41.9)
Radiological characteristics
CXR findings (n = 145) Parenchymal (nodules,
infiltrates, masses)
114 (78.6)
Cavities 51 (35.2)
Pleural (pleural effusion,
pleural thickening)
28 (19.3)
Adenopathy (hilar & mediastinal) 4 (2.8)
Mycobacteriology characteristics
Smear Negative 123 (47.3%)
Positive 137 (52.7%)
Culture and drug
sensitivity
Negative 165 (63.5%)
Positive 95 (36.5%)
Any drug resistance
(INH, R, Z, E)
20 (21.1%)
MDR 6 (6.3%)
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5.4% (7 of 130). Although only 7 patients had blood
sugars levels diagnostic of diabetes, another 12 patients
(9.2%) had blood sugar levels diagnostic of pre-diabetes.
Current smoking was 1.4% (5 of 365) but history of
smoking was reported by at 26.3% (96 of 365) of the pa-
tients and 52.6% of former smokers reported to have
quit in the past one year.
Poverty was found in 39.5%(144 of 365) while over-
crowding was reported by 57.3% (209 of 365) patients.
One hundred and eighty five patients (50.7%) reported
alcohol use.
More patients (57.6%) from overcrowded homes were
smear positive compared to those from homes without
overcrowding (47.1%), prevalence ratio (PR) of 1.22,
p = 0.09. We however found no other significant differen-
ces in the clinical, radiological and mycobacteriological TB
disease presentation between other risk factors (Table 3).
Discussion
In this cross sectional study among TB patients under
care in Kampala, Uganda we have established the preva-
lence of key known TB risk factors as follows: HIV infec-
tion 41.4%, alcohol use 50.7%, poverty 39.5%, smoking
26.3%, family history of TB 17.5%, TB contact 11.5% and
diabetes 5.4%.
High prevalence of HIV among TB patients is due to
HIV associated immune suppression which increases
risk for TB through reactivation of latent TB disease and
increased proportion of persons who progress from TB
infection to disease. The annual risk of TB among HIV
patients is 10%/year compared to the 10% life time risk
among HIV negative persons [28]. The prevalence of
HIV found in this study is about 6 times (41.4 vs.7.3)
that in the general population. The prevalence is how-
ever lower than the over 50% prevalence previously re-
ported [1]. This difference could be because of the small
sample size and small number of recruitment sites.
However, a study investigating prevalence of MDR-TB
by Lukoye D et al. reported lower HIV prevalence of
30.5% compared to the current study [29].
The association between tobacco smoking and TB is
well described [15,17,30]. The prevalence we report in
this study does not differ significantly from those re-
ported in other studies in Africa [31] but differs from
those in other regions [32]. For example a study in
South Africa reported a prevalence of 21.8% while a
study in Malaysia reported a prevalence of 40.3% [33].
These differences could be attributed to background
smoking prevalence in the general population. The preva-
lence of background tobacco smoking in Uganda popula-
tion is limited because population based surveys have not
been conducted. A review conducted by Nturibi EM et al.
identified three studies on tobacco smoking prevalence in
Uganda [34]. The prevalence in these studies ranged
from 5.3% to 21.9% [35]. It must be noted all the three
studies included mainly young people in schools. An un-
published fact sheet from the recently concluded GATS
tobacco use survey in Uganda reported a prevalence of
12% in the general population (http://www.afro.who.
int/en/uganda/press-materials/item/6713-uganda-releases-
results-of-the-global-adult-tobacco-survey-2013.html). We
also noted that the prevalence of current smoking was
only 1.37% but on further evaluation it was found that
about half of the former smokers had actually quit in
the past year. This could be due to fact that most
patients stopped smoking when they developed TB
respiratory symptoms interpreting them as due to
smoking.
Previous studies have documented a strong association
of diabetes and TB [18,36]. A recent meta-analysis has
found a strong association (relative risk of 3.1) between
TB and diabetes [18]. The prevalence reported in this
study is lower than that reported in a recent study
among hospitalized TB patients in Mulago Hospital,
Kampala [34]. This difference could be due to the fact
that stress hyperglycemia in the hospitalized patients
may have contributed to more patients being diagnosed
with diabetes. The study also used random blood sugar
instead of the recommended fasting blood sugar. In
addition 12 patients met the criteria of pre-diabetes.
Taking the pre-diabetes and the diabetes together gives a
prevalence of 10.8% comparable to what was found in
the Mulago hospital study.
We investigated the number of patients whose daily
incomes were below the poverty line and how many
were living in overcrowded homes. The prevalence of
poverty we found (39.5%) was slightly higher than the
national average of 38% [37]. We note that this study
was conducted in the capital city of Uganda. Therefore
patients’ incomes may be higher than 1.25 USD/day des-
ignated by the World Bank. In the 2012–2013 when the
study was conducted 1.25 USD/day could barely afford a
Table 2 Prevalence of studied tuberculosis risk factors
among study participants
Risk factor Number with
risk factor
% (95% CI)
Income below poverty line
(1.25 USD/day)
144 39.5 (34.4-44.7)
Overcrowding (>2 persons/room) 209 57.3 (52.0-62.4)
Former smoker 96 26.3 (21.9-31.1)
Current smoker 5 1.4 (0.4-3.2)
Alcohol use 185 50.7 (45.4-55.9)
HIV infection 151 41.4 (36.3-46.6)
TB contact 42 11.5 (8.4-15.2)
Family history of TB 64 17.5 (13.8-21.8)
Diabetes 7 5.4 (3.1-6.7)
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simple lunch meal. In essence this cut off may grossly
underestimate the poverty levels of the populace espe-
cially those in urban areas. Uganda with 53% of the
population living in overcrowded homes is number 14
on the list of the 20 countries with most overcrowded
homes in the world [26]. Overcrowding has been previ-
ously documented as a strong risk for TB [38]. In this
study we found that 57.3% of the study participants were
living in overcrowded homes. This is higher than the na-
tional average. The national figures do not take into ac-
count the TB burden in the community. The study area
(Kampala) has the highest prevalence of TB in the coun-
try. One in four TB cases notified in Uganda are from
Kampala [20]. Therefore overcrowding may represent a
greater risk of TB than in areas where the TB is much
lower.
Close contact is another well described risk factor for
TB [39-44]. Close contact was estimated to account for
9-13% of the TB cases in Malawi [44]. In a systematic re-
view by Fox GJ et al. the prevalence of active TB and la-
tent TB infection among TB contacts was 3.1% and
51.5% respectively [40]. A prevalence of 3.1 represents a
major increase in TB prevalence compared to the gen-
eral population. For example in Uganda TB prevalence is
175/100,000 population (0.02%) [1]. It follows therefore
that TB prevalence among contacts is very high [1]. The
odds ratio of having a family member with TB and
developing TB is estimated at 13.4 further highlighting
the importance of close TB contact and TB risk [6].
This factor is not well studied among patients in most
TB programs. We contend that a prevalence of family
history of TB of 17.5 is high and need further investi-
gations. This would mean that beyond close contacts
health workers would elicit family history of TB, the pres-
ence of which would refine targeting of TB screening
strategies.
We also investigated the prevalence of alcohol use
among TB patients. The association of TB and alcohol is
well described in the literature [45,46]. It can be hypoth-
esized that it is due to the close contact that takes place
in bars as opposed to other social gatherings. Lanoroth
K et al. conducted a systematic review in which they
established that alcohol use was independently associ-
ated with TB (RR 2.94). More than 50% of the TB pa-
tients in our study consumed alcohol. Although we
investigated the effect of the studied risk factors on TB
disease presentation we did not find significant influence
of the risk factors on disease presentation. Marginal in-
fluence was observed between overcrowding and smear
positive rate. This could be due to the fact that our study
was not powered to detect these differences. Secondly
we enrolled patients at different stages of treatment
which could have affected the prevalence of the out-
comes variables.
Lastly we found an MDR rate of 6.3% and all were
from new patients. This prevalence is much higher than
that found in the national drug resistance survey con-
ducted in 2010 (1.4%) and that found in the Kampala
drug resistance survey conducted in 2008 (1.1%) [29,47].
This difference could be due to smaller sample size since
we had only 95 culture positive patients. It could also be
sampling bias because we included only government
Table 3 Tuberculosis risk factors and selected tuberculosis disease presentation
Independent
variables
Smear positive PR (SE),
p value
Abnormal chest x-ray PR (SE),
p value
Chronic cough PR (SE),
p valueN (%) N (%) N (%)
Poverty
Yes 17 (53.1) 1.10 (0.21) 12 (37.5) 1.07 (0.28) 15 (46.9) 0.81 (0.16
No 61 (48.4) 0.625 44 (34.9) 0.783 73 (57.9) 0.296
Overcrowding
Yes 80 (57.6) 1.22 (0.15) 54 (38.9) 1.04 (0.17) 80 (57.6) 1.09 (0.12)
No 57 (47.1) 0.097 45 (37.2) 0.784 64 (52.9) 0.453
Smoking
Yes 45 (58.4) 1.16 (0.14) 27 (35.1) 0.89 (0.16) 40 (52.0) 0.92 (0.12)
No 92 (50.6) 0.230 72 (39.6) 0.503 103 (56.6) 0.501
Alcohol use
Yes 77 (55.8) 1.13 (0.14) 50 (36.2) 0.90 (0.14) 78 (56.5) 1.04 (0.12)
No 60 (49.2) 0.290 49 (40.2) 0.514 66 (54.1) 0.695
HIV infection
Positive 128 (52.9) 1.1 (0.26) 90 (37.2) 0.74 (0.19) 137 (56.6) 1.46 (0.44)
Negative 9 (50.0) 0.817 9 (50.0) 0.237 7 (38.9) 0.212
PR = Prevalence Ratio, SE = Standard Error.
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DTUs and enrolled patients during one reporting quar-
ter. We also included TB patients irrespective of dur-
ation on TB treatment. Therefore some new patients
could have started developing drug resistance during the
time they were on TB treatment. We also noted that
during the study period there were drug stock outs at
study clinics. This could have further facilitated emer-
gence of drug resistance among study patients. These
shortcomings not withstanding these results emphasize
the role of surveillance of drug resistance. A follow up
survey or analysis of routinely collected data can help
clarify if there could be increase in drug resistance in the
country.
This study had some limitations. Firstly the patients
were recruited over one quarter of the reporting year. It
is possible that there may be differences in the patients
who reported to the health facilities during other times.
We defined overcrowding using alternative method of
number of persons per room. This method does not take
into account the size of the room. This was done be-
cause we could not obtain accurate room sizes in order
to calculate the living area per person. Patient incomes
were also self –reported. We used daily income as a
measure of poverty. However we recognize that a more
extensive investigation of poverty parameters would pro-
vide different estimates. We did not take into consider-
ation symptoms while making a diagnosis of diabetes as
recommended. Only 86% of the estimated sample size
was achieved under convenient sampling, future studies
with bigger sample size are recommended. Nevertheless,
much as this study is more qualitative than quantitative,
it is one of few studies specifically conducted to investi-
gate the prevalence of TB risk factors among TB pa-
tients. It has generated data that should guide more
detailed, possibly better designed quantitative studies.
Conclusions
Among TB patients in Kampala, Uganda, there is high
prevalence of the known TB risk factors. Targeting redu-
cing their prevalence may lead to better TB control in
the country.
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